Skip to main content
. 2024 Mar 20;14(3):409. doi: 10.3390/life14030409

Figure 2.

Figure 2

Radiopharmaceutical structure. The radiopharmaceutical consisted of a radionuclide (68Ga), a bifunctional chelator (NODAGA) and a targeting vector, known as Z-360. Z-360 is an antagonist of CCK2R, which serves as the molecular target in the study. The labeling reaction was performed at 90 °C, maintaining a pH of 4.5 and achieving a high yield within a 5 min time span.